What is Ophthalmic Solution?
Founded in 2009 and headquartered in Knoxville, Tennessee, Ophthalmic Solution Inc. operates as a specialized manufacturer of intraocular lenses (IOLs) essential for modern cataract surgery. The company has carved out a distinct market niche by delivering a comprehensive portfolio that includes monofocal, multifocal, and toric lenses. By maintaining a rigorous focus on both hydrophilic and hydrophobic material science, OSI provides ophthalmic surgeons with the precision tools required for high-stakes ocular procedures. Their commitment to reliability and responsive service has established them as a trusted partner in the global ophthalmology supply chain, effectively bridging the gap between advanced optical engineering and clinical application.
How much funding has Ophthalmic Solution raised?
Ophthalmic Solution has raised a total of $26K across 1 funding round:
Debt
$26K
Debt (2021): $26K with participation from PPP
Key Investors in Ophthalmic Solution
PPP
Public-Private Partnership
What's next for Ophthalmic Solution?
The infusion of $26K signals a strategic pivot toward scaling production capacity and potentially expanding the firm's research and development pipeline. As the company navigates the complexities of the late-stage growth phase, the focus will likely shift toward increasing market penetration for its trifocal and toric lens offerings. By leveraging this recent financing, OSI is well-positioned to enhance its manufacturing infrastructure, ensuring that it remains at the forefront of surgical innovation. Future growth will be predicated on the company's ability to maintain its reputation for quality while navigating the regulatory and competitive pressures inherent in the global medical device sector.
See full Ophthalmic Solution company page
